Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BJDX
BJDX logo

BJDX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bluejay Diagnostics Inc (BJDX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.140
1 Day change
-1.83%
52 Week Range
16.680
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

BJDX is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has bullish short-term momentum, but the RSI is extremely overbought and there is no supporting news, financial data, or strong institutional/insider accumulation to justify an immediate long-term entry. Since the user is impatient and does not want to wait for an ideal entry, the best direct call is to hold and avoid buying at this level.

Technical Analysis

The technical picture is mixed but stretched. MACD is positive and expanding, which supports short-term upside momentum. However, RSI_6 at 84.573 is deeply overbought, suggesting the recent move may be overextended. Moving averages are converging, which often signals a transition phase rather than a clean long-term uptrend. Price at 2.10 is essentially at the R1 pivot resistance of 2.099 and below the next resistance at 2.23, so upside from here looks limited unless a breakout occurs. The recent pattern data also shows weak next-day and next-month expectations, which adds caution.

Positive Catalysts

  • ["MACD histogram is positive and expanding, showing improving short-term momentum.", "Price has recently shown strength with a regular market gain of 11.51% before the close.", "Current price is near a technical breakout zone around the 2.099 resistance level."]

Neutral/Negative Catalysts

  • ["RSI is extremely overbought at 84.573, which makes the current entry unattractive.", "No news in the recent week, so there is no event-driven catalyst supporting the move.", "No valuation data and no meaningful financial snapshot were available, limiting long-term conviction.", "Hedge funds and insiders are both neutral, so there is no strong accumulation signal.", "No recent congress trading data and no notable politician/influential buying activity reported.", "Pattern-based trend data suggests limited upside and possible short-term pullback."]

Financial Performance

No usable latest-quarter financial snapshot was provided because the financial data returned an error. As a result, there is no reported quarter season or growth trend available to assess. This weakens the case for a long-term buy because the current decision must rely mainly on price action rather than fundamentals.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data was provided. With no recent upgrades, downgrades, or target revisions available, the Wall Street view cannot be confirmed as bullish. Overall pros view: limited because of missing fundamentals and no supporting analyst momentum. Overall cons view: strong because the stock is overbought, lacks recent news catalysts, and has no visible institutional or insider buying trend.

Wall Street analysts forecast BJDX stock price to rise
Analyst Rating
0
Wall Street analysts forecast BJDX stock price to rise
Buy
Hold
Sell
0
Current: 2.180
sliders
Low
0
Averages
0
High
0
0
Current: 2.180
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch